This course moves beyond older treatments to explore how groundbreaking new drug classes are fundamentally changing the disease trajectory. You’ll get a practical masterclass in using single, dual, and triple-agonist therapies (like the latest GLP-1 and GIP drugs) to achieve unprecedented results in both glycemic control and sustainable weight loss. Learn to integrate these powerful agents to secure the cardio-renal health benefits that truly improve your patients’ long-term outcomes. This isn’t just an update—it’s a guide to leading the charge in modern metabolic medicine.